Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer.
Nicholas H ChakiryanDa David JiangKyle A GillisElizabeth GreenAli HajiranLee HugarLogan ZempJingsong ZhangRohit JainJad ChahoudMichael PochBrandon J ManleyRoger LiWade SextonScott M GilbertPublished in: The Journal of urology (2021)
Neoadjuvant chemotherapy was associated with pathological downstaging for all MIBC histological variants, with improved OS for patients with UC, sarcomatoid variant UC and neuroendocrine carcinoma.